Mann JFE, Rossing P, Bakris G, Belmar N, et al. Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial. Nat Med 2024 Jun 24. doi: 10.1038/s41591-024-03133.
PMID: 38914124